Checkpoint Therapeutics buy krebskrebs
Start price
21.02.22
/
50%
€1.69
Target price
21.02.23
€2.50
Performance (%)
-70.34%
End price
22.02.23
€0.50
Summary
This prediction ended on 22.02.23 with a price of €0.50. The BUY prediction by krebskrebs for Checkpoint Therapeutics performed very badly with a performance of -70.34%. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Checkpoint Therapeutics | - | - | - | - |
| iShares Core DAX® | 0,79 % | 1,97 % | 13,39 % | 49,83 % |
| iShares Nasdaq 100 | 4,23 % | 4,34 % | 39,72 % | 89,76 % |
| iShares Nikkei 225® | 3,29 % | 6,99 % | 49,89 % | 64,38 % |
| iShares S&P 500 | 2,50 % | 2,76 % | 30,23 % | 64,25 % |
Comments by krebskrebs for this prediction
In the thread Checkpoint Therapeutics diskutieren
In the thread Trading Checkpoint Therapeutics
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten